Navigation Links
Perrigo Shareholders Approve Proposals Related To Perrigo's Proposed Acquisition Of Elan
Date:11/18/2013

t attributable to shareholders, including estimated synergies, anticipated provisions or write-downs, economic profit, dividends, capital structure or any other financial items or rations; statements of plans, objectives or goals of Perrigo, New Perrigo, Elan or the combined business following the transactions contemplated by the Transaction Agreement; statements about the future trends in tax or interest rates, liquidity, foreign exchange rates, stock market levels and demographic trends and any impact that those matters may have on Perrigo, New Perrigo, Elan or the combined company following the transactions contemplated by the Transaction Agreement; statements concerning any future Irish, UK, US or other economic or regulatory environment or performance; statements about strategic goals, competition, regulation, regulatory approvals, dispositions and consolidation or technological developments in the healthcare and lifesciences industry; and statements of assumptions underlying such statements.

While Perrigo believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond Perrigo's control. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon future circumstances that may or may not occur. Actual results may differ materially from Perrigo's current expectations depending upon a number of factors affecting Perrigo's business, New Perrigo's business, Elan's business and risks associated with acquisition transactions. These factors include, among others, the inherent uncertainty associated with financial projections; restructuring in connection with, and successful close of, the transactions contemplated by the Transaction Agreement; subsequent integration of the transactions contemplated by the Transaction Agreement and the ability to recognize
'/>"/>

SOURCE Perrigo
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Perrigo Company Announces Tender Offer and Consent Solicitation for its 2.950% Notes due 2023
2. Perrigo Initiates Nationwide Voluntary Product Recall Of Acetaminophen Infant Suspension Liquid, 160 mg/5 mL, Due To A Potential Defect With The Co-Packaged Oral Syringe
3. Perrigo Reports Record First Quarter Revenue, Adjusted Earnings And Margins
4. Perrigo Company To Release First Quarter Fiscal Year 2014 Results On October 31, 2013
5. Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue and Earnings
6. Perrigo Nutritionals Works with the American Academy of Pediatrics (AAP) on Infant Nutrition Educational Initiative
7. Perrigo Company Will Release Fourth Quarter And Fiscal Year 2013 Results On August 15, 2013
8. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
9. Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million
10. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
11. Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Amgen (NASDAQ: AMGN ) ... year 2014 financial results on Tuesday, Jan. 27, 2015, after the ... by a conference call with the investment community at 2 p.m. ... A. Bradway , chairman and chief executive officer, and other members ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015 Increasing sophistication ... continued consolidation of localization purchasing in 2015, says ... According to a recent study by market research firm ... a single-source solution for their translation and localization needs. ...
(Date:1/22/2015)... ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has announced the addition of ... by End User - Global Forecast to 2019" report ... market is valued at $1,228.58 million in 2014 and is ... $2,230.72 million by 2019. Allergy diagnostics is used to determine ...
Breaking Medicine Technology:Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
... BELGRADE, Mont., Nov. 15, 2010 Bacterin International Holdings, ... BIHI ), a developer of anti-infective coatings for ... financial results for its third quarter ended September 30, ... the reverse merger transaction reported in the Company,s Form ...
... Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical ... 2010 Scrip Award for "Clinical Research Team of ... at the sixth annual Scrip Awards ceremony, hosted ... information service for the global pharmaceutical industry, on November 4, ...
Cached Medicine Technology:Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 2Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 3Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 4Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 5Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 6Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 7Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 8Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 9PAREXEL Wins Clinical Research Team of the Year Scrip Award 2PAREXEL Wins Clinical Research Team of the Year Scrip Award 3PAREXEL Wins Clinical Research Team of the Year Scrip Award 4PAREXEL Wins Clinical Research Team of the Year Scrip Award 5
(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Four years since the release of their debut ... the marriage of Avasa & Matthew Love – the duo are ... for release through White Swan Records on February 24, 2015. , ... sacred path available to all of us to walk out of ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
(Date:1/22/2015)... USA (PRWEB) January 22, 2015 State ... statewide data management system with support from GEOSYSTEMS, a ... The new solution will leverage Hexagon Geospatial’s ERDAS ... vector data as well as point clouds and documents. ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Oct. 11 At "Managing Quality to,Drive Growth," ... LLC,s,Global Benchmarking Council (GBC), executives from 20 leading ... for quality and,growth; product innovation excellence; process simplification ... successes in integrating quality into,sales, marketing and new ...
... ALOKA Co., Ltd., a pioneer in the,development ... Masanobu Tada as President, and Carlos Faustmann as ... the company,s,wholly-owned European headquarters in Zug, Switzerland, with ... Global Marketing of the company as,general manager since ...
... YORK, Oct. 10 Molina Healthcare Inc. (NYSE: MOH ... in the S&P,SmallCap 600 after the close of trading on ... constituent LKQ Corp. (Nasdaq: LKQX ) in,a deal that ... final,approvals. Standard & Poor,s will monitor this transaction, and ...
... PORTLAND, Ore., Oct. 10 Mark Ganz, President and ... a prominent group of,thought leaders and health policy experts ... major initiative to reframe and broaden the,national dialogue on ... and beyond. The Aspen Health Stewardship Project will ...
... performed equally in high-tech tests , , WEDNESDAY, Oct. 10 ... runners should follow Prince Charming,s lead and consider a ... , Using high-tech methods, a team of Scottish scientists ... between $80 pairs of running shoes and pairs made ...
... to Protect Health Benefit, MARYSVILLE, Calif., Oct. 10 ... to announce the filing of a,formal grievance over the ... caregivers earlier this year. Because of the county,s ... residents who are elderly or have disabilities must play,a ...
Cached Medicine News:Health News:Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development 2Health News:ALOKA Appoints New Management in Europe 2Health News:Standard & Poor's Announces Change to U.S. Index 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Pricey Running Shoes Not Worth It: Study 2Health News:Pricey Running Shoes Not Worth It: Study 3Health News:Pricey Running Shoes Not Worth It: Study 4Health News:Caregivers Demand County Honor Their Contract 2
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Trueview Classic is,lightweight, comfortable and durable....
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Halogen III Classic is,lightweight, comfortable and durable....
Mounted on a sturdy, molded headband,the Classic has a fully adjustable,crown strap and cushioning that adds,to your comfort....
... InterGro DBM putty is a ... most trusted names in human tissue ... in bone grafting technology. InterGro ... lipid carrier (lecithin) to deliver a ...
Medicine Products: